Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
2007 1
2008 3
2011 2
2012 4
2013 2
2022 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB; UNITY Study Group. Moise KJ Jr, et al. N Engl J Med. 2024 Aug 8;391(6):526-537. doi: 10.1056/NEJMoa2314466. N Engl J Med. 2024. PMID: 39115062 Clinical Trial.
Forced degradation studies of rapamycin: identification of autoxidation products.
Oyler AR, Segmuller BE, Sun Y, Polshyna A, Dunphy R, Armstrong BL, Achord P, Maryanoff CA, Alquier L, Il'ichev YV. Oyler AR, et al. Among authors: alquier l. J Pharm Biomed Anal. 2012 Feb 5;59:194-200. doi: 10.1016/j.jpba.2011.10.017. Epub 2011 Oct 21. J Pharm Biomed Anal. 2012. PMID: 22088479
Mass balance in rapamycin autoxidation.
Oyler AR, Armstrong BL, Dunphy R, Alquier L, Maryanoff CA, Cohen JH, Merciadez M, Khublall A, Mehta R, Patel A, Il'ichev YV. Oyler AR, et al. Among authors: alquier l. J Pharm Biomed Anal. 2008 Dec 15;48(5):1368-74. doi: 10.1016/j.jpba.2008.09.030. Epub 2008 Sep 30. J Pharm Biomed Anal. 2008. PMID: 19019612
Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
Pai H, Ndjeka N, Mbuagbaw L, Kaniga K, Birmingham E, Mao G, Alquier L, Davis K, Bodard A, Williams A, Van Tongel M, Thoret-Bauchet F, Omar SV, Bakare N. Pai H, et al. Among authors: alquier l. BMC Infect Dis. 2022 Nov 21;22(1):870. doi: 10.1186/s12879-022-07861-x. BMC Infect Dis. 2022. PMID: 36414938 Free PMC article.
A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea.
Shim TS, Pai H, Mok J, Lee SH, Kwon YS, Choi JC, Park J, Birmingham E, Mao G, Alquier L, Davis K, Thoret-Bauchet F, Kim JH, Kim H, Bakare N. Shim TS, et al. Among authors: alquier l. BMC Infect Dis. 2023 Jan 9;23(1):15. doi: 10.1186/s12879-022-07955-6. BMC Infect Dis. 2023. PMID: 36624432 Free PMC article.
14 results